Clinical evidence suggests that gender differences frequently exist in genetic forms of lipodystrophy, such as CGL2 or familial partial lipodystrophy (Dunnigan type), where female patients often exhibit a more severe physical and metabolic phenotype than male patients [46,47,48]. Here, GZMH is linked to lipodystrophy.